| Literature DB >> 25228861 |
Dasuni S Alwis1, Ramesh Rajan1.
Abstract
The brain's life-long capacity for experience-dependent plasticity allows adaptation to new environments or to changes in the environment, and to changes in internal brain states such as occurs in brain damage. Since the initial discovery by Hebb (1947) that environmental enrichment (EE) was able to confer improvements in cognitive behavior, EE has been investigated as a powerful form of experience-dependent plasticity. Animal studies have shown that exposure to EE results in a number of molecular and morphological alterations, which are thought to underpin changes in neuronal function and ultimately, behavior. These consequences of EE make it ideally suited for investigation into its use as a potential therapy after neurological disorders, such as traumatic brain injury (TBI). In this review, we aim to first briefly discuss the effects of EE on behavior and neuronal function, followed by a review of the underlying molecular and structural changes that account for EE-dependent plasticity in the normal (uninjured) adult brain. We then extend this review to specifically address the role of EE in the treatment of experimental TBI, where we will discuss the demonstrated sensorimotor and cognitive benefits associated with exposure to EE, and their possible mechanisms. Finally, we will explore the use of EE-based rehabilitation in the treatment of human TBI patients, highlighting the remaining questions regarding the effects of EE.Entities:
Keywords: EE; neuronal excitability; sensory cortices; traumatic brain injury
Year: 2014 PMID: 25228861 PMCID: PMC4151031 DOI: 10.3389/fnsys.2014.00156
Source DB: PubMed Journal: Front Syst Neurosci ISSN: 1662-5137
Figure 1Environmental enrichment induces morphological and molecular changes in the brain. An overview of the number of structural and molecular mechanisms that contribute to the changes in neuronal function, and ultimately, changes in behavior, seen after EE exposure. These mechanisms are thought to underlie EE-induced neural plasticity.
Behavioral, morphological, and molecular effects of EE in various neurological disease conditions.
| Stroke/hypoxia-ischemia | Improved motor function (reaching, beam-walk, rotating pole) | Increased dendritic length and branching in cortex | Increased growth factor expression | Ohlsson and Johansson, |
| Improved declarative memory (Novel object recognition test) | Preserved dendritic spine density loss/increased spine density in hippocampus, cortex | |||
| Improved spatial learning and memory (Morris water maze, Radial arm maze) | Decreased cortical infarct volume | |||
| Enhances cell proliferation | ||||
| Lesions | Improved motor function (posture, ladder climb) | Increased dendritic length in cerebellum | Increased growth factor expression | Kelche and Will, |
| Improved spatial learning and memory (Morris water maze) | Increased dendritic branching and spine density in hippocampus, cortex | |||
| Epilepsy | Increased seizure resistance | Decreased hippocampal cell death | Increased growth factor expression | Young et al., |
| Increased exploratory activity (Open field) | Increased neurogenesis | Enhanced expression of neuronal and synaptic plasticity mediators | ||
| Improved spatial learning (Morris water maze) | ||||
| Huntington's disease | Delayed onset of motor deficits | Delays degenerative loss of cerebral volume | Increased growth factor expression | Van Dellen et al., |
| Improved spatial memory (Barnes maze, Morris water maze) | Attenuates deficits in hippocampal neurogenesis | Increased synaptic protein expression | ||
| Reduced aggregation of huntingtin protein fragments | ||||
| Alzheimer's disease | Improved spatial learning and memory (Morris water maze, Barnes maze) | Increased/decreased Aβ and amyloid deposition | Increased growth factor expression | Jankowsky et al., |
| Improved working memory (Radial arm water maze) | Increased neuronal progenitor cell proliferation | Increased synaptophysin expression | ||
| Increased/decreased neurogenesis Decreased progenitor cell survival | ||||
| Parkinson's disease | Improved motor function (skilled reaching task) | Decreased dopaminergic neuron and transporter loss | Increased growth factor expression | Bezard et al., |
| Decreased cell death |
Summary of findings from studies that have investigated the effects of EE after various neurological conditions.
Figure 2Behavioral benefits conferred by the timing/duration of EE relative to creation of TBI. The efficacy of EE treatment when administered pre/post-injury is represented by green full-line arrows which indicate EE timing conditions that ameliorated behaviors, while white dashed arrows indicate EE timing conditions that failed to ameliorate behaviors.